Bharat Parenterals Ltd

Bharat Parenter. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Bharat Parenterals Ltd

₹ 1,270 1.75%
20 May 10:51 a.m.
bplindia.in BSE: 541096
About

Incorporated in 1992, Bharat Parenterals Ltd is in the business of manufacturing and marketing of formulations[1]

Key Points

Business Overview:[1]
BPL is a Gujarat-based WHO GMP & an ISO 10002: 2014, 9001: 2015 certified pharmaceutical company. It manufactures over 800 products spread over 20+ different categories including General Products, β-Lactum/ Cephalosporin Products, Formulations in the form of Tablets, Capsules, Liquid- orals, Ointments, Creams, Lotions, and most importantly Powdered Injections and small Volume Parenterals both in Ampoules and Vials.

Website BSE
  • Market Cap ₹ 875 Cr.
  • Current Price ₹ 1,270
  • High / Low ₹ 1,667 / 880
  • Stock P/E 54.6
  • Book Value ₹ 584
  • Dividend Yield 0.08 %
  • ROCE 5.79 %
  • ROE 4.06 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • The company has delivered a poor sales growth of 2.82% over past five years.
  • Company has a low return on equity of 7.33% over last 3 years.
  • Earnings include an other income of Rs.12.6 Cr.
  • Dividend payout has been low at 3.16% of profits over last 3 years
  • Company has high debtors of 188 days.
  • Promoter holding has decreased over last 3 years: -6.67%
  • Working capital days have increased from 113 days to 172 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
50.97 69.91 59.81 58.80 65.64 92.06 64.45 67.34 80.28 94.37 41.70 41.41 56.54
44.38 58.42 53.38 52.02 61.91 77.07 58.79 58.99 75.68 79.11 39.36 37.94 56.51
Operating Profit 6.59 11.49 6.43 6.78 3.73 14.99 5.66 8.35 4.60 15.26 2.34 3.47 0.03
OPM % 12.93% 16.44% 10.75% 11.53% 5.68% 16.28% 8.78% 12.40% 5.73% 16.17% 5.61% 8.38% 0.05%
6.96 2.86 3.46 2.40 3.24 3.90 4.60 3.79 2.26 1.62 4.21 2.28 4.44
Interest 0.80 0.88 0.61 0.61 1.09 1.02 0.88 1.41 1.48 1.42 0.96 0.55 0.51
Depreciation 1.43 1.51 1.61 1.67 1.61 1.61 1.75 1.86 1.82 2.06 2.17 2.10 2.04
Profit before tax 11.32 11.96 7.67 6.90 4.27 16.26 7.63 8.87 3.56 13.40 3.42 3.10 1.92
Tax % 17.93% 25.67% 27.51% 26.52% 28.10% 25.09% 28.05% 26.61% 35.96% 25.37% 20.18% 38.06% 28.65%
9.29 8.89 5.56 5.07 3.07 12.18 5.49 6.50 2.28 10.00 2.73 1.92 1.38
EPS in Rs 16.09 15.39 9.55 8.71 5.28 18.67 8.41 9.43 3.31 14.51 3.96 2.79 2.00
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
119 125 111 136 220 226 204 212 218 258 304 234
108 114 104 123 189 196 179 183 196 225 269 213
Operating Profit 11 10 7 13 30 30 25 29 22 33 35 21
OPM % 9% 8% 6% 10% 14% 13% 12% 14% 10% 13% 11% 9%
4 5 8 7 13 11 9 7 19 8 14 13
Interest 2 1 1 1 1 1 1 1 3 4 5 3
Depreciation 4 4 6 6 6 6 6 7 6 6 7 8
Profit before tax 9 9 8 14 36 35 27 28 32 31 36 22
Tax % 15% 31% 7% 27% 37% 25% 25% 25% 24% 27% 27% 27%
7 6 7 10 23 26 20 21 24 23 26 16
EPS in Rs 12.98 11.26 12.88 17.63 39.39 45.90 35.27 36.89 42.15 38.82 38.38 23.24
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 2% 3% 3% 4%
Compounded Sales Growth
10 Years: 6%
5 Years: 3%
3 Years: 2%
TTM: -23%
Compounded Profit Growth
10 Years: 10%
5 Years: -4%
3 Years: -7%
TTM: -41%
Stock Price CAGR
10 Years: %
5 Years: 26%
3 Years: 56%
1 Year: 14%
Return on Equity
10 Years: 11%
5 Years: 9%
3 Years: 7%
Last Year: 4%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 6 6 6 6 6 6 6 6 6 6 7 7
Reserves 44 51 58 69 91 117 138 160 185 208 380 395
16 19 6 9 5 1 12 15 46 83 65 20
50 44 40 50 60 68 40 37 71 91 98 98
Total Liabilities 116 120 111 133 161 192 196 218 308 387 549 520
29 35 31 34 35 33 45 41 36 39 46 51
CWIP 0 0 0 0 1 12 0 1 0 0 5 6
Investments 0 0 1 1 2 0 42 16 38 49 168 195
87 85 79 99 123 147 110 160 233 299 330 269
Total Assets 116 120 111 133 161 192 196 218 308 387 549 520

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
0 -2 6 20 14 30 -22 -12 -0 19 45
0 -2 -8 -9 -13 -46 22 -14 -38 -90 4
0 -8 4 -4 -3 8 2 29 34 69 -49
Net Cash Flow 0 -11 2 7 -1 -8 2 3 -5 -1 -0
Free Cash Flow 0 -4 -2 11 -0 24 -27 -7 -10 -1 30
CFO/OP 0% -4% 67% 102% 81% 145% -56% -13% 28% 85% 250%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 179 129 144 158 109 132 122 126 188 198 198 188
Inventory Days 55 62 69 60 55 69 61 56 100 125 90 131
Days Payable 188 171 167 110 82 106 71 60 127 121 121 97
Cash Conversion Cycle 47 20 46 108 82 95 111 122 161 202 167 222
Working Capital Days 58 8 65 82 78 97 111 150 98 68 100 172
ROCE % 17% 15% 12% 19% 40% 32% 20% 18% 14% 13% 11% 6%

Insights

In beta
Mar 2019 Mar 2020 Mar 2022 Mar 2025
Export Presence (Number of Countries)
Number

Log in to view insights

Please log in to see hidden values.

Login
Number of Product Dossiers / Approved Products
Number
Domestic Field Force (Varenyam Healthcare)
Number of MRs
Hospital Reach (Domestic)
Number of Hospitals
Manufacturing Lines (BPL Standalone)
Number

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
73.84% 73.84% 73.84% 73.27% 73.27% 65.35% 67.20% 67.20% 67.19% 67.19% 67.19% 67.17%
0.00% 0.00% 0.00% 0.00% 0.00% 0.08% 0.11% 0.11% 0.11% 0.11% 0.11% 0.11%
0.01% 0.01% 0.01% 0.01% 0.01% 0.57% 0.54% 0.54% 0.54% 0.54% 0.54% 1.07%
26.16% 26.15% 26.15% 26.72% 26.72% 33.98% 32.16% 32.15% 32.16% 32.16% 32.17% 31.65%
No. of Shareholders 2,4852,4812,3972,4972,7082,7483,1163,1773,2313,2053,1723,095

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Concalls

  • May 2026
    Transcript
    AI Summary
    PPT
  • Jan 2026
    Transcript
    AI Summary
    PPT
  • Nov 2025
    Transcript PPT
  • Jul 2025
    Transcript
    AI Summary
    PPT
  • May 2025
    Transcript
    PPT
  • May 2024
    Transcript
    AI Summary
    PPT
  • Feb 2024
    Transcript
    AI Summary
    PPT